Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1990-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.87.14.5368PMID 2164681PMCID PMC54325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine

  2004cited by this paper
• High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic mice.

  1990cited by this paper
• Enhanced O6-methylguanine-DNA methyltransferase activity in transgenic mice containing an integrated E. coli ada repair gene.

  1989cited by this paper
• Repair of O6-methylguanine, O6-ethylguanine, O6-isopropylguanine and O4-methylthymine in synthetic oligodeoxynucleotides by Escherichia coli ada gene O6-alkylguanine-DNA-alkyltransferase.

  1989cited by this paper
• Modulation of O6-alkylguanine-DNA alkyltransferase in rats following intravenous administration of O6-methylguanine.

  1989cited by this paper
• Modulation of human lymphocyte O6-alkylguanine-DNA alkyltransferase by streptozotocin in vivo.

  1989cited by this paper
• Purification of the E. coli ogt gene product to homogeneity and its rate of action on O6-methylguanine, O6-ethylguanine and O4-methylthymine in dodecadeoxyribonucleotides.

  1989cited by this paper
• Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.

  1989cited by this paper
• Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells.

  1989cited by this paper
• Site-specifically modified oligodeoxynucleotides as probes for the structural and biological effects of DNA-damaging agents.

  1988cited by this paper
• Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.

  1988cited by this paper
• Repair of O-alkylpyrimidines in mammalian cells: a present consensus.

  1988cited by this paper
• Modulation of nitrosourea resistance in myeloid leukemias.

  1988cited by this paper
• Use of oligodeoxynucleotides containing O6-alkylguanine for the assay of O6-alkylguanine-DNA-alkyltransferase activity.

  1988cited by this paper
• Regulation and expression of the adaptive response to alkylating agents.

  1988cited by this paper
• Synthesis and properties of H-ras DNA sequences containing O6-substituted 2'-deoxyguanosine residues at the first, second, or both positions of codon 12.

  1988cited by this paper
• Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides.

  1988cited by this paper
• Alternative pathways for the in vivo repair of O6‐alkylguanine and O4‐alkylthymine in Escherichia coli: the adaptive response and nucleotide excision repair.

  1988cited by this paper
• Transfectant CHO cells expressing O6-alkylguanine-DNA-alkyltransferase display increased resistance to DNA damage other than O6-guanine alkylation.

  1987cited by this paper
• Properties and assay of mammalian O6-alkylguanine-DNA alkyltransferase.

  1987cited by this paper
• Inactivation of O6-methylguanine-DNA methyltransferase and sensitization of human tumor cells to killing by chloroethylnitrosourea by O6-methylguanine as a free base.

  1986cited by this paper
• Prevention of 1-(3-deoxycytidyl),2-(1-deoxyguanosinyl)ethane cross-link formation in DNA by rat liver O6-alkylguanine-DNA alkyltransferase.

  1986cited by this paper
• Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene.

  1986cited by this paper
• Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes.

  1986cited by this paper
• Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.

  1986cited by this paper
• Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster ovary cells by expression of a cloned bacterial DNA repair gene.

  1986cited by this paper
• Transfer of the E. coli O6-methylguanine methyltransferase gene into repair-deficient human cells and restoration of cellular resistance to N-methyl-N'-nitro-N-nitrosoguanidine.

  1986cited by this paper
• Repair of oligodeoxynucleotides containing O6-methylguanine by O6-alkylguanine-DNA-alkyltransferase.

  1986cited by this paper
• Isolation and purification of O6-alkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme.

  1985cited by this paper
• Mechanisms of carcinogenesis induced by alkylating agents.

  1985cited by this paper
• Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.

  1985cited by this paper
• The role of O6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis.

  1985cited by this paper
• DNA-mediated transfer and expression of a human DNA repair gene that demethylates O6-methylguanine

  1985cited by this paper
• Repair of O6-propylguanine and O6-butylguanine in DNA by O6-alkylguanine-DNA alkyltransferases from rat liver and E. coli.

  1985cited by this paper
• Possible depletion of a DNA repair enzyme in human lymphoma cells by subversive repair.

  1985cited by this paper
• The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions.

  1985cited by this paper
• Comparison of the rates of repair of O6-alkylguanines in DNA by rat liver and bacterial O6-alkylguanine-DNA alkyltransferase.

  1984cited by this paper
• Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.

  1984cited by this paper
• Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents.

  1984cited by this paper
• Mechanism of action of the nitrosoureas--V. Formation of O6-(2-fluoroethyl)guanine and its probable role in the crosslinking of deoxyribonucleic acid.

  1983cited by this paper
• Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase.

  1983cited by this paper
• Purification and properties of O6-methylguanine-DNA transmethylase from rat liver.

  1983cited by this paper
• Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea.

  1982cited by this paper
• Repair of O6-ethylguanine in DNA by a chromatin fraction from rat liver: transfer of the ethyl group to an acceptor protein.

  1981cited by this paper
• DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.

  1980cited by this paper
• DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.

  1978cited by this paper
• Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Allylic rearrangement from O6 to C-8 in the guanine series.

  1973cited by this paper
• Mechanism and Structure in Organic Chemistry

  1969cited by this paper
• SYNTHESIS AND ANTITUMOR ACTIVITY OF 9-(TETRAHYDRO-2-FURYL)PURINE ANALOGS OF BIOLOGICALLY IMPORTANT DEOXYNUCLEOSIDES.

  1963cited by this paper

• Reduction mechanism of XOR-mediated nitroaromatics hypoxia targeted AGT inhibitors: Molecular docking, MD simulation and ONIOM (QM/MM) investigation.

  2025cites this paper
• Temozolomide-Derived Therapeutic Strategies to Overcome Resistance in Glioblastoma.

  2025cites this paper
• Novel Strategies for Improved Treatment of O6-Methylguanine-DNA Methyltransferase Promoter-Methylated Glioma

  2025cites this paper
• The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer

  2024cites this paper
• Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells

  2024cites this paper
• A Tween-80 modified hypoxia/esterase dual stimulus-activated nanomicelle as a delivery platform for carmustine - Design, synthesis, and biological evaluation.

  2024cites this paper
• CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate

  2023cites this paper
• QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency

  2023cites this paper
• Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability.

  2023cites this paper
• Hypoxia and CD44 receptors dual-targeted nano-micelles with AGT-inhibitory activity for the targeting delivery of carmustine.

  2023cites this paper
• New Biotech tool from Hot Sources: Thermostable self-labeling protein-tags near to the boiling water

  2022cites this paper
• Double-strand breaks: When DNA repair events accidentally meet.

  2022cites this paper
• Unraveling key interactions and the mechanism of demethylation during hAGT-mediated DNA repair via simulations

  2022cites this paper
• Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O‑6‑Methylguanine‑DNA Methyltransferase.

  2022cites this paper
• The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for Melanoma

  2022cites this paper
• Repair of O6-carboxymethylguanine adducts by O6-methylguanine-DNA methyltransferase in human colon epithelial cells.

  2021cites this paper
• From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas

  2021cites this paper
• Covalent 18F-Radiotracers for SNAPTag: A New Toolbox for Reporter Gene Imaging

  2021cites this paper
• Acridine-O6-benzylguanine hybrids: Synthesis, DNA binding, MGMT inhibition and antiproliferative activity.

  2021cites this paper
• Unboxing the molecular modalities of mutagens in cancer

  2021cites this paper
• The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme

  2020cites this paper
• Repair of DN 4 containing O 6-alltrIguanine

  2020cites this paper
• MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

  2020cites this paper
• The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites

  2020cites this paper
• Precision oncology : oncogenic stat3 signalling in brain tumours

  2019cites this paper
• Repair and translesion synthesis of O6-alkylguanine DNA lesions in human cells

  2019cites this paper
• Hypoxia-targeted drug delivery.

  2019cites this paper
• Mechanism of colorectal carcinogenesis triggered by heme iron from red meat.

  2019cites this paper
• Emerging novel prognostic markers in pancreatic ductal adenocarcinoma

  2018cites this paper
• Effect of paraoxonase (PON1) on lactones and ROS induced DNA damage

  2018cites this paper
• Glycosylation of the Pyrrolopyrimdine and Its Cyclisation into Tricyclic Nucleoside for Incorporation into Synthetic DNA

  2018cites this paper
• Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule

  2018cites this paper
• The specific role of O6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy.

  2018cites this paper
• Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo

  2018cites this paper
• Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.

  2018cites this paper
• MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide

  2018cites this paper
• A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells

  2017cites this paper
• Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer

  2017cites this paper
• Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities.

  2017cites this paper
• Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking

  2016cites this paper
• MGMT in colorectal cancer: a promising component of personalized treatment

  2016cites this paper
• Au/TiO2 nanobelt heterostructures for the detection of cancer cells and anticancer drug activity by potential sensing

  2016cites this paper
• Antitumor sulfonylhydrazines: design, structure-activity relationships, resistance mechanisms, and strategies for improving therapeutic utility.

  2015cites this paper
• MGMT Inhibition Suppresses Survivin Expression in Pancreatic Cancer

  2015cites this paper
• Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection

  2015cites this paper
• Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)

  2015cites this paper
• Implications of BRCA1 mutations in basal-like breast cancer development and treatment

  2015influential citation
• Crystal shape engineering of anatase TiO2 and its biomedical applications

  2015cites this paper
• Repair mechanisms help glioblastoma resist treatment.

  2015cites this paper
• Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells

  2015cites this paper
• Inhibition of DNA Repair as a Therapeutic Target

  2014cites this paper
• An Easy-to-use Genotoxicity Assay Using EGFP-MDC1-expressing Human Cells

  2014cites this paper
• Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice

  2014cites this paper
• Comprehensive analysis of DNA methylation and gene expression of rat liver in a 2-stage hepatocarcinogenesis model.

  2014cites this paper
• Nanoparticle based strategies for the treatment of Glioblastoma

  2014cites this paper
• Acetylation of Werner syndrome protein (WRN): relationships with DNA damage, DNA replication and DNA metabolic activities

  2014cites this paper
• MGMT testing—the challenges for biomarker-based glioma treatment

  2014cites this paper
• Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.

  2014cites this paper
• Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer

  2014cites this paper
• Investigations on the effect of O(6)-benzylguanine on the formation of dG-dC interstrand cross-links induced by chloroethylnitrosoureas in human glioma cells using stable isotope dilution high-performance liquid chromatography electrospray ionization tandem mass spectrometry.

  2014cites this paper
• N3-Substituted Temozolomide Analogs Overcome Methylguanine-DNA Methyltransferase and Mismatch Repair Precipitating Apoptotic and Autophagic Cancer Cell Death

  2014cites this paper
• Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations

  2013cites this paper
• Foamy Virus Vectors for HIV Gene Therapy

  2013cites this paper
• Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice

  2013cites this paper
• Nano-p-n junction heterostructure TiO2 nanobelts for the electrochemical detection of anticancer drug and biointeractions with cancer cells.

  2013cites this paper
• Computational Approaches for Structure Based Drug Design and Protein Structure-Function Prediction

  2013cites this paper
• Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer

  2013cites this paper
• Genetic and Epigenetic Alterations in Primary–Progressive Paired Oligodendroglial Tumors

  2013cites this paper
• A Newly Uncovered Group of Distantly Related Lysine Methyltransferases Preferentially Interact with Molecular Chaperones to Regulate Their Activity

  2013cites this paper
• O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.

  2013cites this paper
• Human Cells Alkyltransferase and Nucleotide Excision Repair Activities in O2-Ethylthymine, Is Dependent upon O6-Alkylguanine-DNA Efficient Repair of O6-Ethylguanine, but not O4-Ethylthymine or

  2013cites this paper
• MGMT: A Critical DNA Repair Gene Target for Chemotherapy Resistance and for Stem Cell Protection

  2012cites this paper
• Probing the binding of interstrand crosslinked DNA containing a fluorescent base analog with human and E. coli homologs of O6-alkyl-guanine-DNA-alkyltransferase

  2012cites this paper
• Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.

  2012cites this paper
• DNA repair mechanisms protect our genome from carcinogenesis.

  2012cites this paper
• Die Methylierung von NEUROG-1 ist ein diagnostischer Marker im Serum von Patienten mit kolorektalen Karzinomen

  2012cites this paper
• Role of nonhomologous end-joining in oral cancer and personalized pharmacogenomics

  2012cites this paper
• Endogenous anticancer mechanisms (EACMs).

  2012cites this paper
• Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.

  2012cites this paper
• Formation and repair of pyridyloxobutyl DNA adducts and their relationship to tumor yield in A/J mice.

  2012cites this paper
• Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia

  2012cites this paper
• MGMT Inhibition Restores ERα Functional Sensitivity to Antiestrogen Therapy

  2012cites this paper
• O(6)-Methylguanine-DNA Methyltransferase Is a Novel Negative Effector of Invasion in Glioblastoma Multiforme

  2012cites this paper
• Predictive role of XRCC5/XRCC6 genotypes in digestive system cancers.

  2011cites this paper
• Clonal Inventory Screens Uncover Monoclonality Following Serial Transplantation of MGMT P140K-Transduced Stem Cells and Dose-Intense Chemotherapy

  2011cites this paper
• Role of the XRCC5/XRCC6 dimer in carcinogenesis and pharmacogenomics.

  2011cites this paper
• Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity

  2011cites this paper
• GENOTOXIN-INDUCED ACETYLATION OF THE WERNER SYNDROME PROTEIN (WRN) AND EFFECT ON ITS DNA METABOLIC FUNCTION

  2011cites this paper
• Cell-Centric View of Apoptosis and Apoptotic Cell Death-Inducing Antitumoral Strategies

  2011influential citation
• Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools.

  2011cites this paper
• The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.

  2011cites this paper
• 4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.

  2011cites this paper
• Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model

  2011cites this paper
• O6-Alkylguanine-DNA Alkyltransferase

  2011cites this paper
• Drug delivery systems to include liposomes and microparticles in order to aid treatment of glioma.

  2011cites this paper
• p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage.

  2011cites this paper
• Acquired Resistance to Temozolomide in Glioma Cell Lines: Molecular Mechanisms and Potential Translational Applications

  2010cites this paper
• Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K

  2010cites this paper
• Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models

  2010cites this paper
• Targeting O6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy

  2010influential citation